These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9347871)

  • 1. Heparin-induced thrombocytopenia as an autoimmune disease--idiotypic evidence for the role of anti-heparin/PF4 autoantibodies.
    Shoenfeld Y
    Isr J Med Sci; 1997 Apr; 33(4):243-5. PubMed ID: 9347871
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection and significance of heparin-platelet factor 4 antibodies.
    Francis JL
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S9-14. PubMed ID: 16105558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to heparin-platelet factor 4 complex: pathogenesis, epidemiology, and management of heparin-induced thrombocytopenia in hemodialysis.
    Davenport A
    Am J Kidney Dis; 2009 Aug; 54(2):361-74. PubMed ID: 19481318
    [No Abstract]   [Full Text] [Related]  

  • 4. Crossreactivity studies between sera of patients with heparin associated thrombocytopenia and a new low molecular weight heparin, reviparin.
    Greinacher A; Feigl M; Mueller-Eckhardt C
    Thromb Haemost; 1994 Oct; 72(4):644-5. PubMed ID: 7878646
    [No Abstract]   [Full Text] [Related]  

  • 5. Confirmatory procedure and other maneuvers to assess pathogenicity of platelet factor 4 (PF4)-dependent antibodies--distinguishing "signal" from "noise".
    Warkentin TE
    Thromb Haemost; 2008 Oct; 100(4):523-4. PubMed ID: 18841271
    [No Abstract]   [Full Text] [Related]  

  • 6. Heparin-induced thrombocytopenia: molecular pathogenesis.
    Visentin GP
    Thromb Haemost; 1999 Aug; 82(2):448-56. PubMed ID: 10605736
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin.
    Blank M; Cines DB; Arepally G; Eldor A; Afek A; Shoenfeld Y
    Clin Exp Immunol; 1997 May; 108(2):333-9. PubMed ID: 9158107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin-induced thrombocytopenia: diagnosis and management.
    Warkentin TE
    Circulation; 2004 Nov; 110(18):e454-8. PubMed ID: 15520327
    [No Abstract]   [Full Text] [Related]  

  • 9. Delayed-onset heparin-induced thrombocytopenia and cerebral thrombosis after a single administration of unfractionated heparin.
    Warkentin TE; Bernstein RA
    N Engl J Med; 2003 Mar; 348(11):1067-9. PubMed ID: 12637624
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparin-induced thrombocytopenia in neurologic patients treated with low-molecular-weight heparin.
    Pohl C; Kredteck A; Bastians B; Hanfland P; Klockgether T; Harbrecht U
    Neurology; 2005 Apr; 64(7):1285-7. PubMed ID: 15824368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role for mouse marginal zone B cells in PF4/heparin antibody production.
    Zheng Y; Yu M; Podd A; Yuan L; Newman DK; Wen R; Arepally G; Wang D
    Blood; 2013 Apr; 121(17):3484-92. PubMed ID: 23460609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
    Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
    J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative thrombocytopenia in cardiac surgical patients - incidence of heparin-induced thrombocytopenia, morbidities and mortality.
    Thielmann M; Bunschkowski M; Tossios P; Selleng S; Marggraf G; Greinacher A; Jakob H; Massoudy P
    Eur J Cardiothorac Surg; 2010 Jun; 37(6):1391-5. PubMed ID: 20138779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients.
    Kannan M; Saxena R; Adiguzel C; Fareed J
    Semin Thromb Hemost; 2009 Apr; 35(3):337-43. PubMed ID: 19452409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia: IgG binding to PF4-heparin complexes in the fluid phase and cross-reactivity with low molecular weight heparin and heparinoid.
    Newman PM; Swanson RL; Chong BH
    Thromb Haemost; 1998 Aug; 80(2):292-7. PubMed ID: 9716155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia.
    Alberio L; Kimmerle S; Baumann A; Taleghani BM; Biasiutti FD; Lämmle B
    Am J Med; 2003 May; 114(7):528-36. PubMed ID: 12753876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing for heparin-induced thrombocytopenia antibodies.
    Warkentin TE; Sheppard JA
    Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute cardiorespiratory collapse from heparin: a consequence of heparin-induced thrombocytopenia.
    Mims MP; Manian P; Rice L
    Eur J Haematol; 2004 May; 72(5):366-9. PubMed ID: 15059074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. eComment: Heparin-induced thrombocytopenia.
    Bockeria L; Samsonova N; Klimovich L
    Interact Cardiovasc Thorac Surg; 2009 Dec; 9(6):1025. PubMed ID: 19919964
    [No Abstract]   [Full Text] [Related]  

  • 20. Urgent cardiac surgery in a patient with a remote history of heparin-induced thrombocytopenia: use of the anti-PF4/heparin ELISA confirmatory test.
    Dellaria SM; Greilich PE; Sarode R
    Anesth Analg; 2008 Aug; 107(2):379-81. PubMed ID: 18633011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.